市場調査レポート

商品コード

1762564

ヒト血小板溶解液の世界市場：市場規模・シェア・動向、業界分析 (用途別・種類別・最終用途別・地域別)、将来予測 (2025年～2034年)

Human Platelet Lysate Market Size, Share, Trends, & Industry Analysis Report: By Application (Research and Therapeutic), By Type, By End Use, By Region - Market Forecast, 2025-2034

出版日: 2025年06月01日
発行: Polaris Market Research
ページ情報: 英文 113 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 624,282円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 771,172円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 918,062円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.89円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のヒト血小板溶解液の市場規模は2034年までに7,848万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ヒト血小板溶解液（HPL）は、生物医学研究や再生医療の分野で極めて重要な成分として登場し、細胞培養技術や治療用途に革命をもたらしています。ヒト血小板由来のこの汎用性の高い製品は、牛胎児血清（FBS）のような従来の細胞培養サプリメントに比べ、数多くの利点を提供します。HPLに対する需要の高まりは、その安全性、効率性、倫理的配慮など、いくつかの促進要因に起因しています。

ヒト血小板溶解液（HPL）市場は、科学の進歩や現実のヘルスケアニーズによって成長しています。世界各国の政府は、資金提供、助成金、規制上の支援によって再生医療に多額の投資を行っています。このような努力は、安全かつ効果的に細胞を増殖・拡大させるためにヒト血小板溶解液に依存する新たな治療を探求する科学者や企業を後押ししています。このような支援によって、この分野に対する信頼が築かれ、幹細胞治療がより迅速に進展するようになりました。さらに、パーキンソン病、変形性関節症、脱毛症（androgenetic alopecia）などの慢性疾患の増加が、HPL市場の成長を牽引しています。これらの疾患は、人口の高齢化とライフスタイルの変化により、より一般的になりつつあります。現在、これらの疾患の多くは治療の選択肢が限られており、そのため医師や研究者は再生医療に目を向けています。血小板溶解液は、損傷した組織の修復と再生を助ける天然の成長因子を含んでいるため、こうした新しい治療法においてより頻繁に使用されるようになっています。

規制状況はHPL市場の成長に貢献しています。多くの国の規制機関は、倫理的に調達された安全な細胞培養サプリメントの使用を含む、より安全で透明性の高い研究慣行を提唱しています。良好な安全性と倫理的プロファイルを持つHPLは、こうした規制要件に合致し、臨床試験や治療応用の承認プロセスを容易にします。

ヒト血小板溶解液市場：分析概要

種類別では、ヘパリンフリーベースのヒト血小板溶解液セグメントがヒト血小板溶解液市場シェアを独占しています。これは、規制遵守、安全性、臨床および研究環境における広範な適用性において有利なためです。ヘパリンフリーのHPLは、細胞培養や再生医療において重要な成分として浮上しており、従来の成長サプリメントに代わる無血清の選択肢を提供しています。

用途別では、研究用分野は予測期間中にCAGR 3.5%を記録すると予想されています。この急成長は、細胞培養研究において牛胎児血清の優れた代替品としてヒト血小板溶解液の使用が増加していることに起因しています。ヒト血小板溶解液は間葉系幹細胞、免疫細胞、その他のヒト由来細胞の増殖に不可欠な成長因子を豊富に含んでおり、前臨床研究やトランスレーショナル研究に理想的です。

2024年のヒト血小板溶解液市場の売上高シェアは、北米が圧倒的でした。北米は、多能性幹細胞、人工多能性幹細胞（iPSC）、成体幹細胞を含む幹細胞研究の拠点です。HPLは、発生過程の研究や治療への応用のために、これらの細胞を培養し、増殖させるために使用されています。米国では、幹細胞培養は再生医療と生物医学研究の領域で基本的な要素として機能しています。

欧州のヒト血小板溶解液市場は、同地域が生物医学研究に重点を置いていること、再生医療分野が拡大していること、規制状況が良好であることから、大きな成長を遂げています。

世界の主な市場参入企業は、Merck KGaA、Compass Biomedical Inc.、PL BioScience、AventaCell BioMedical Corp、Mill Creek Lifesciences LLC、Stem Cell Technologies Inc、Zen Bio, Inc.、Sclavo Diagnostics International Sr、Lifescience Group Limited、Trinova Biochem GmbHなどです。

ヒト血小板溶解液：市場スナップショット
バリューチェーン分析
- ヒト血小板溶解液市場の力学
- 促進要因と機会
  - 主要企業や政府による幹細胞治療の研究開発（R&D）活動の増加
  - パーキンソン病、変形性関節症、男性型脱毛症などの慢性疾患の有病率の増加
- 抑制要因と課題
  - 高額な費用と感染症の伝染リスクの増加
ポーターのファイブフォース分析
- 代替品の脅威：（低）
- 新規参入業者の脅威：（低～中）
- 買い手の交渉力：（中）
- 供給企業の交渉力：（中～高）
- 競争企業間の敵対関係：（中～高）
PESTLE分析
COVID-19の影響分析と業界動向

第5章ヒト血小板溶解液市場の評価：種類別

イントロダクション
ヘパリンベース・ヒト血小板溶解液
ヘパリンフリー・ヒト血小板溶解液

第6章ヒト血小板溶解液市場の評価：用途別

イントロダクション
研究用
治療用

第7章ヒト血小板溶解液市場の評価：エンドユーザー別

イントロダクション
製薬・バイオテクノロジー企業
学術研究機関
その他

第8章ヒト血小板溶解液市場の分析：地域別

イントロダクション
北米
- 北米のヒト血小板溶解液市場：種類別
- 北米のヒト血小板溶解液市場：用途別
- エンドユーザー別
- 米国
- カナダ
欧州
- 欧州のヒト血小板溶解液市場：種類別
- 欧州のヒト血小板溶解液市場：用途別
- エンドユーザー別
- フランス
- ドイツ
- 英国
- イタリア
- オランダ
- スペイン
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋のヒト血小板溶解液市場：種類別
- アジア太平洋のヒト血小板溶解液市場：用途別
- エンドユーザー別
- 日本
- 中国
- インド
- マレーシア
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
ラテンアメリカ
- ラテンアメリカのヒト血小板溶解液市場：種類別
- ラテンアメリカのヒト血小板溶解液市場：用途別
- エンドユーザー別
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ
中東アフリカ
- 中東・アフリカのヒト血小板溶解液市場：種類別
- 中東・アフリカのヒト血小板溶解液市場：用途別
- エンドユーザー別
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ
- その他中東・アフリカ

第9章競合情勢

市場の主要企業：分類
戦略的枠組み
ベンダー情勢
戦略の分類
- 最近の動向

第10章企業プロファイル

Merck KGaA
Compass Biomedical, Inc.
PL BioScience GmbH
AventaCell BioMedical Corp.
Mill Creek Life Sciences
Stem Cell Technology, Inc.
ZenBio, Inc.
SCLAVO Diagnostics International
Lifescience Group Limited
Trinova Biochem GmbH

図表

List of Tables

Table 1 Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 2 Human Platelet Lysate Market, By Heparin Based Human Platelet Lysate, 2021 - 2034 (USD Million)
Table 3 Human Platelet Lysate Market, By Heparin Free Based Human Platelet Lysate, 2021 - 2034 (USD Million)
Table 4 Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 5 Human Platelet Lysate Market, By Research, 2021 - 2034 (USD Million)
Table 6 Human Platelet Lysate Market, By Therapeutic, 2021 - 2034 (USD Million)
Table 7 Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 8 Human Platelet Lysate Market, By Pharmaceutical & Biotechnological Companies, 2021 - 2034 (USD Million)
Table 9 Human Platelet Lysate Market, By Academic & Research Institutes, 2021 - 2034 (USD Million)
Table 10 Human Platelet Lysate Market, By Others, 2021 - 2034 (USD Million)
Table 11 Human Platelet Lysate Market Assessment, By Geography, 2021 - 2034 (USD Million)
Table 12 North America Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 13 North America Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 14 North America Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 15 U.S. Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 16 U.S. Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 17 U.S. Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 18 Canada Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 19 Canada Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 20 Canada Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 21 Europe Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 22 Europe Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 23 Europe Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 24 France Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 25 France Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 26 France Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 27 Germany Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 28 Germany Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 29 Germany Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 30 U.K. Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 31 U.K. Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 32 U.K. Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 33 Italy Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 34 Italy Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 35 Italy Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 36 Netherlands Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 37 Netherlands Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 38 Netherlands Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 39 Spain Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 40 Spain Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 41 Spain Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 42 Russia Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 43 Russia Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 44 Russia Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 45 Rest of Europe Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 46 Rest of Europe Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 47 Rest of Europe Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 48 Asia Pacific Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 49 Asia Pacific Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 50 Asia Pacific Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 51 Japan Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 52 Japan Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 53 Japan Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 54 China Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 55 China Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 56 China Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 57 India Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 58 India Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 59 India Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 60 Malaysia Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 61 Malaysia Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 62 Malaysia Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 63 Indonesia Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 64 Indonesia Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 65 Indonesia Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 66 South Korea Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 67 South Korea Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 68 South Korea Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 69 Australia Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 70 Australia Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 71 Australia Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 72 Rest of APAC Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 73 Rest of APAC Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 74 Rest of APAC Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 75 Latin America Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 76 Latin America Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 77 Latin America Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 78 Mexico Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 79 Mexico Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 80 Mexico Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 81 Brazil Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 82 Brazil Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 83 Brazil Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 84 Argentina Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 85 Argentina Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 86 Argentina Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 87 Rest of Latin America Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 88 Rest of Latin America Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 89 Rest of Latin America Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 90 Middle East Africa Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 91 Middle East Africa Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 92 Middle East Africa Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 93 Saudi Arabia Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 94 Saudi Arabia Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 95 Saudi Arabia Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 96 UAE Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 97 UAE Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 98 UAE Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 99 South Africa Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 100 South Africa Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 101 South Africa Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)
Table 102 Rest of MEA Human Platelet Lysate Market, By Type, 2021 - 2034 (USD Million)
Table 103 Rest of MEA Human Platelet Lysate Market, By Application, 2021 - 2034 (USD Million)
Table 104 Rest of MEA Human Platelet Lysate Market, By End-User, 2021 - 2034 (USD Million)

List of Figures

Figure 1. Information Procurement
Figure 2. Primary Research Pattern
Figure 3. Primary research process
Figure 4. Market research approaches - Bottom-Up Approach
Figure 5. Market research approaches - Top-Down Approach
Figure 6. Market research approaches - Combined Approach
Figure 7. Executive Summary
Figure 8. Market by Region, 2022 (USD Million)
Figure 9. Human Platelet Lysate Market, 2021 - 2034 (USD Million)
Figure 10. Value Chain Analysis
Figure 11. Porter's Five Forces
Figure 12. PESTLE Analysis
Figure 13. Market by Type
Figure 14. Human Platelet Lysate Market, By Type, 2024 & 2034 (USD Million)
Figure 15. Market by Application
Figure 16. Human Platelet Lysate Market, By Application, 2024 & 2034 (USD Million)
Figure 17. Market by End-User
Figure 18. Human Platelet Lysate Market, By End-User, 2024 & 2034 (USD Million)
Figure 19. Human Platelet Lysate Market Assessment, By Geography, 2024 & 2034 (USD Million)

Product Code: PM3990

The global human platelet lysate market size is expected to reach USD 78.48 million by 2034, according to a new study by Polaris Market Research. The report "Human Platelet Lysate Market Size, Share, Trends, & Industry Analysis Report: By Application (Research and Therapeutic), By Type, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human Platelet Lysate (HPL) has emerged as a pivotal component in the field of biomedical research and regenerative medicine, revolutionizing cell culture techniques and therapeutic applications. This versatile product, derived from human blood platelets, offers numerous advantages over traditional cell culture supplements such as Fetal Bovine Serum (FBS). The growing demand for HPL can be attributed to several driving factors, including its safety, efficiency, and ethical considerations.

The human platelet lysate (HPL) market is growing due to scientific advancements and real-world healthcare needs. Governments across the world are investing heavily in regenerative medicine by providing funding, grants, and regulatory support. These efforts are encouraging scientists and companies to explore new treatments that rely on human platelet lysate to grow and expand cells safely and effectively. This support has helped build trust in the field and led to faster progress in stem cell therapy. Additionally, the rising number of chronic diseases such as Parkinson's disease, osteoarthritis, and hair loss (androgenetic alopecia) is driving the HPL market growth. These conditions are becoming more common due to aging populations and changing lifestyles. Many of them currently have limited treatment options, which is why doctors and researchers are turning to regenerative medicine. Platelet lysate is being used more often in these new therapies as it contains natural growth factors that help repair and regenerate damaged tissues.

The regulatory landscape has contributed to the growth of the HPL market. Regulatory bodies in many countries have been advocating for safer and more transparent research practices, which include the use of ethically sourced and safe cell culture supplements. HPL, with its favorable safety and ethical profiles, aligns with these regulatory requirements, easing the approval processes for clinical trials and therapeutic applications.

Human Platelet Lysate Market Report Highlights

By type, the heparin free based human platelet lysate segment dominated the human platelet lysate market share, due to its advantages in regulatory compliance, safety, and broader applicability in clinical and research settings. Heparin-free HPL has emerged as a critical component in cell culture and regenerative medicine, offering a serum-free alternative to traditional growth supplements.

By application, the research segment is expected to register a CAGR of 3.5% during the forecast period. The rapid growth is attributed to the growing use of human platelet lysate as a superior alternative to fetal bovine serum in cell culture research. It provides rich growth factors essential for expanding mesenchymal stem cells, immune cells, and other human-derived cells, making it ideal for preclinical and translational studies.

North America dominated the global human platelet lysate market revenue share in 2024. North America is a hub for stem cell research, encompassing pluripotent stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells. HPL is employed to culture and expand these cells for research into developmental processes and therapeutic applications. In the US, stem cell culture serves as a fundamental element in the realms of regenerative medicine and biomedical research.

The human platelet lysate market in Europe is experiencing significant growth, owing to the region's strong emphasis on biomedical research, expanding regenerative medicine sector, and favorable regulatory landscape.

A few global key market players are Merck KGaA; Compass Biomedical Inc.; PL BioScience; AventaCell BioMedical Corp; Mill Creek Lifesciences LLC; Stem Cell Technologies Inc; Zen Bio, Inc.; Sclavo Diagnostics International Sr; Lifescience Group Limited; and Trinova Biochem GmbH.

Polaris Market Research has segmented the human platelet lysate market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue, USD Million, 2020-2034)

Heparin Based HPL

Heparin Free HPL

By Application Outlook (Revenue, USD Million, 2020-2034)

Research

Therapeutic

By End Use Outlook (Revenue, USD Million, 2020-2034)

Pharmaceutical & Biotechnological Companies

Academic & Research Institutes

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Malaysia

Australia

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Chapter 1. Introduction

1.1 Report Description
- 1.1.1 Objective of the Study
- 1.1.2 Market Scope
- 1.1.3 Assumptions
1.2 Stakeholders

Chapter 2. Research Methodology

2.1 Research Methodology
2.2 Research Scope and Assumptions
2.3 Information Procurement
- 2.3.1 Purchased Database
- 2.3.2 Internal Database
- 2.3.3 Secondary Sources
- 2.3.4 Third Party Perspective
- 2.3.5 Primary Research
2.4 Information Analysis
- 2.4.1 Data Analysis Models
2.5 Market Formulation and Data Visualization
2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

4.1 Human Platelet Lysate - Industry snapshot
4.2 Human Platelet Lysate Market - Value Chain Analysis
- 4.2.1 Human Platelet Lysate Market Dynamics
- 4.2.2 Drivers and Opportunities
  - 4.2.2.1 Increasing in the research and development (R&D) activities of stem cell therapy by leading companies and governments
  - 4.2.2.2 Increasing prevalence of chronic diseases such as Parkinson's disease, osteoarthritis, androgenetic alopecia and others
- 4.2.3 Restraints and Challenges
  - 4.2.3.1 High cost and increased risk of transmission of infectious communicable diseases
4.3 Human Platelet Lysate Market - Porter's Five Forces
- 4.3.1 Threat of Substitutes: (Low)
- 4.3.2 Threat of New Entrants: (Low to Moderate)
- 4.3.3 Bargaining power of buyers: (Moderate)
- 4.3.4 Bargaining power of suppliers: (Moderate to High)
- 4.3.5 Competitive Rivalry: (Moderate to High)
4.4 Human Platelet Lysate Market - PESTLE Analysis
4.5 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Human Platelet Lysate Market Assessment by Type

5.1 Introduction
5.2 Heparin Based Human Platelet Lysate
5.3 Heparin Free Based Human Platelet Lysate

Chapter 6. Human Platelet Lysate Market Assessment by Application

6.1 Introduction
6.2 Research
6.3 Therapeutic

Chapter 7. Human Platelet Lysate Market Assessment by End-User

7.1 Introduction
7.2 Pharmaceutical & Biotechnological Companies
7.3 Academic & Research Institutes
7.4 Others

Chapter 8. Human Platelet Lysate Market Assessment by Region

8.1 Introduction
8.2 Human Platelet Lysate Market - North America
- 8.2.1 North America Human Platelet Lysate, By Type
- 8.2.2 North America Human Platelet Lysate, By Application
- 8.2.3 North America Human Platelet Lysate Market, By End-User
- 8.2.4 Human Platelet Lysate Market - U.S.
  - 8.2.4.1 U.S. Human Platelet Lysate, By Type
  - 8.2.4.2 U.S. Human Platelet Lysate, By Application
  - 8.2.4.3 U.S. Human Platelet Lysate Market, By End-User
- 8.2.5 Human Platelet Lysate Market - Canada
  - 8.2.5.1 Canada Human Platelet Lysate, By Type
  - 8.2.5.2 Canada Human Platelet Lysate, By Application
  - 8.2.5.3 Canada Human Platelet Lysate Market, By End-User
8.3 Human Platelet Lysate Market - Europe
- 8.3.1 Europe Human Platelet Lysate, By Type
- 8.3.2 Europe Human Platelet Lysate, By Application
- 8.3.3 Europe Human Platelet Lysate Market, By End-User
- 8.3.4 Human Platelet Lysate Market - France
  - 8.3.4.1 France Human Platelet Lysate, By Type
  - 8.3.4.2 France Human Platelet Lysate, By Application
  - 8.3.4.3 France Human Platelet Lysate Market, By End-User
- 8.3.5 Human Platelet Lysate Market - Germany
  - 8.3.5.1 Germany Human Platelet Lysate, By Type
  - 8.3.5.2 Germany Human Platelet Lysate, By Application
  - 8.3.5.3 Germany Human Platelet Lysate Market, By End-User
- 8.3.6 Human Platelet Lysate Market - UK
  - 8.3.6.1 U.K. Human Platelet Lysate, By Type
  - 8.3.6.2 U.K. Human Platelet Lysate, By Application
  - 8.3.6.3 U.K. Human Platelet Lysate Market, By End-User
- 8.3.7 Human Platelet Lysate Market - Italy
  - 8.3.7.1 Italy Human Platelet Lysate, By Type
  - 8.3.7.2 Italy Human Platelet Lysate, By Application
  - 8.3.7.3 Italy Human Platelet Lysate Market, By End-User
- 8.3.8 Human Platelet Lysate Market - Netherlands
  - 8.3.8.1 Netherlands Human Platelet Lysate, By Type
  - 8.3.8.2 Netherlands Human Platelet Lysate, By Application
  - 8.3.8.3 Netherlands Human Platelet Lysate Market, By End-User
- 8.3.9 Human Platelet Lysate Market - Spain
  - 8.3.9.1 Spain Human Platelet Lysate, By Type
  - 8.3.9.2 Spain Human Platelet Lysate, By Application
  - 8.3.9.3 Spain Human Platelet Lysate Market, By End-User
- 8.3.10 Human Platelet Lysate Market - Russia
  - 8.3.10.1 Russia Human Platelet Lysate, By Type
  - 8.3.10.2 Russia Human Platelet Lysate, By Application
  - 8.3.10.3 Russia Human Platelet Lysate Market, By End-User
- 8.3.11 Human Platelet Lysate Market - Rest of Europe
  - 8.3.11.1 Rest of Europe Human Platelet Lysate, By Type
  - 8.3.11.2 Rest of Europe Human Platelet Lysate, By Application
  - 8.3.11.3 Rest of Europe Human Platelet Lysate Market, By End-User
8.4 Human Platelet Lysate Market - Asia Pacific
- 8.4.1 Asia Pacific Human Platelet Lysate, By Type
- 8.4.2 Asia Pacific Human Platelet Lysate, By Application
- 8.4.3 Asia Pacific Human Platelet Lysate Market, By End-User
- 8.4.4 Human Platelet Lysate Market - Japan
  - 8.4.4.1 Japan Human Platelet Lysate, By Type
  - 8.4.4.2 Japan Human Platelet Lysate, By Application
  - 8.4.4.3 Japan Human Platelet Lysate Market, By End-User
- 8.4.5 Human Platelet Lysate Market - China
  - 8.4.5.1 China Human Platelet Lysate, By Type
  - 8.4.5.2 China Human Platelet Lysate, By Application
  - 8.4.5.3 China Human Platelet Lysate Market, By End-User
- 8.4.6 Human Platelet Lysate Market - India
  - 8.4.6.1 India Human Platelet Lysate, By Type
  - 8.4.6.2 India Human Platelet Lysate, By Application
  - 8.4.6.3 India Human Platelet Lysate Market, By End-User
- 8.4.7 Human Platelet Lysate Market - Malaysia
  - 8.4.7.1 Malaysia Human Platelet Lysate, By Type
  - 8.4.7.2 Malaysia Human Platelet Lysate, By Application
  - 8.4.7.3 Malaysia Human Platelet Lysate Market, By End-User
- 8.4.8 Human Platelet Lysate Market - Indonesia
  - 8.4.8.1 Indonesia Human Platelet Lysate, By Type
  - 8.4.8.2 Indonesia Human Platelet Lysate, By Application
  - 8.4.8.3 Indonesia Human Platelet Lysate Market, By End-User
- 8.4.9 Human Platelet Lysate Market - South Korea
  - 8.4.9.1 South Korea Human Platelet Lysate, By Type
  - 8.4.9.2 South Korea Human Platelet Lysate, By Application
  - 8.4.9.3 South Korea Human Platelet Lysate Market, By End-User
- 8.4.10 Human Platelet Lysate Market - Australia
  - 8.4.10.1 Australia Human Platelet Lysate, By Type
  - 8.4.10.2 Australia Human Platelet Lysate, By Application
  - 8.4.10.3 Australia Human Platelet Lysate Market, By End-User
- 8.4.11 Human Platelet Lysate Market - Rest of APAC
  - 8.4.11.1 Rest of APAC Human Platelet Lysate, By Type
  - 8.4.11.2 Rest of APAC Human Platelet Lysate, By Application
  - 8.4.11.3 Rest of APAC Human Platelet Lysate Market, By End-User
8.5 Human Platelet Lysate Market - Latin America
- 8.5.1 Latin America Human Platelet Lysate, By Type
- 8.5.2 Latin America Human Platelet Lysate, By Application
- 8.5.3 Latin America Human Platelet Lysate Market, By End-User
- 8.5.4 Human Platelet Lysate Market - Mexico
  - 8.5.4.1 Mexico Human Platelet Lysate, By Type
  - 8.5.4.2 Mexico Human Platelet Lysate, By Application
  - 8.5.4.3 Mexico Human Platelet Lysate Market, By End-User
- 8.5.5 Human Platelet Lysate Market - Brazil
  - 8.5.5.1 Brazil Human Platelet Lysate, By Type
  - 8.5.5.2 Brazil Human Platelet Lysate, By Application
  - 8.5.5.3 Brazil Human Platelet Lysate Market, By End-User
- 8.5.6 Human Platelet Lysate Market - Argentina
  - 8.5.6.1 Argentina Human Platelet Lysate, By Type
  - 8.5.6.2 Argentina Human Platelet Lysate, By Application
  - 8.5.6.3 Argentina Human Platelet Lysate Market, By End-User
- 8.5.7 Human Platelet Lysate Market - Rest of Latin America
  - 8.5.7.1 Rest of Latin America Human Platelet Lysate, By Type
  - 8.5.7.2 Rest of Latin America Human Platelet Lysate, By Application
  - 8.5.7.3 Rest of Latin America Human Platelet Lysate Market, By End-User
8.6 Human Platelet Lysate Market - Middle East Africa
- 8.6.1 Middle East Africa Human Platelet Lysate, By Type
- 8.6.2 Middle East Africa Human Platelet Lysate, By Application
- 8.6.3 Middle East Africa Human Platelet Lysate Market, By End-User
- 8.6.4 Human Platelet Lysate Market - Saudi Arabia
  - 8.6.4.1 Saudi Arabia Human Platelet Lysate, By Type
  - 8.6.4.2 Saudi Arabia Human Platelet Lysate, By Application
  - 8.6.4.3 Saudi Arabia Human Platelet Lysate Market, By End-User
- 8.6.5 Human Platelet Lysate Market - UAE
  - 8.6.5.1 UAE Human Platelet Lysate, By Type
  - 8.6.5.2 UAE Human Platelet Lysate, By Application
  - 8.6.5.3 UAE Human Platelet Lysate Market, By End-User
- 8.6.6 Human Platelet Lysate Market - South Africa
  - 8.6.6.1 South Africa Human Platelet Lysate, By Type
  - 8.6.6.2 South Africa Human Platelet Lysate, By Application
  - 8.6.6.3 South Africa Human Platelet Lysate Market, By End-User
- 8.6.7 Human Platelet Lysate Market - Rest of MEA
  - 8.6.7.1 Rest of MEA Human Platelet Lysate, By Type
  - 8.6.7.2 Rest of MEA Human Platelet Lysate, By Application
  - 8.6.7.3 Rest of MEA Human Platelet Lysate Market, By End-User

Chapter 9. Competitive Landscape

9.1 Key Market Players: Categorization
9.2 Strategy Framework
9.3 Vendor Landscape
9.4 Strategies Categorization
- 9.4.1 Recent Development

Chapter 10. Company Profiles

10.1 Merck KGaA
- 10.1.1 Business Overview
- 10.1.2 Financial Snapshot
  - 10.1.2.1 Revenue by Market Segment
  - 10.1.2.2 Revenue by Region
- 10.1.3 Products and Services
10.2 Compass Biomedical, Inc.
- 10.2.1 Business Overview
- 10.2.2 Products and Services
10.3 PL BioScience GmbH
- 10.3.1 Business Overview
- 10.3.2 Products and Services
- 10.3.3 Recent Developments
10.4 AventaCell BioMedical Corp.
- 10.4.1 Business Overview
- 10.4.2 Products and Services
10.5 Mill Creek Life Sciences
- 10.5.1 Business Overview
- 10.5.2 Products and Services
10.6 Stem Cell Technology, Inc.
- 10.6.1 Business Overview
- 10.6.2 Products and Services
- 10.6.3 Recent Developments
10.7 ZenBio, Inc.
- 10.7.1 Business Overview
- 10.7.2 Products and Services
10.8 SCLAVO Diagnostics International
- 10.8.1 Business Overview
- 10.8.2 Products and Services
10.9 Lifescience Group Limited
- 10.9.1 Business Overview
- 10.9.2 Products and Services
10.10 Trinova Biochem GmbH
- 10.10.1 Business Overview
- 10.10.2 Products and Services

ヒト血小板溶解液の世界市場：市場規模・シェア・動向、業界分析 (用途別・種類別・最終用途別・地域別)、将来予測 (2025年～2034年)

Human Platelet Lysate Market Size, Share, Trends, & Industry Analysis Report: By Application (Research and Therapeutic), By Type, By End Use, By Region - Market Forecast, 2025-2034

ヒト血小板溶解液市場：分析概要

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章市場の洞察

第5章ヒト血小板溶解液市場の評価：種類別

第6章ヒト血小板溶解液市場の評価：用途別

第7章ヒト血小板溶解液市場の評価：エンドユーザー別

第8章ヒト血小板溶解液市場の分析：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables

List of Figures

Human Platelet Lysate Market Report Highlights

Table of Contents

Chapter 1. Introduction

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Market Insights

Chapter 5. Human Platelet Lysate Market Assessment by Type

Chapter 6. Human Platelet Lysate Market Assessment by Application

Chapter 7. Human Platelet Lysate Market Assessment by End-User

Chapter 8. Human Platelet Lysate Market Assessment by Region

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

ヒト血小板溶解液の世界市場：市場規模・シェア・動向、業界分析 (用途別・種類別・最終用途別・地域別)、将来予測 (2025年～2034年)

Human Platelet Lysate Market Size, Share, Trends, & Industry Analysis Report: By Application (Research and Therapeutic), By Type, By End Use, By Region - Market Forecast, 2025-2034

ヒト血小板溶解液市場：分析概要

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 市場の洞察

第5章 ヒト血小板溶解液市場の評価：種類別

第6章 ヒト血小板溶解液市場の評価：用途別

第7章 ヒト血小板溶解液市場の評価：エンドユーザー別

第8章 ヒト血小板溶解液市場の分析：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables

List of Figures

Human Platelet Lysate Market Report Highlights

Table of Contents

Chapter 1. Introduction

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Market Insights

Chapter 5. Human Platelet Lysate Market Assessment by Type

Chapter 6. Human Platelet Lysate Market Assessment by Application

Chapter 7. Human Platelet Lysate Market Assessment by End-User

Chapter 8. Human Platelet Lysate Market Assessment by Region

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章市場の洞察

第5章ヒト血小板溶解液市場の評価：種類別

第6章ヒト血小板溶解液市場の評価：用途別

第7章ヒト血小板溶解液市場の評価：エンドユーザー別

第8章ヒト血小板溶解液市場の分析：地域別

第9章競合情勢

第10章企業プロファイル